Portfolio

HealthMedia, Inc.

Delivers tailored behavioral support programs to health management organizations and pharmaceutical companies
(1998)

Integrated Sensing Systems, Inc (ISSYS)

Advanced micro-machining technologies for medical devices and scientific analytical sensing applications
(1998)

IntraLase

Medical device company that developed an automated procedure for laser vision correction, procedure known as "IntraLasik" or "Bladeless Lasik"
(1998)

Nanocerox, Inc.

Oxide ceramics and nanopowders (Formerly Tal Materials, Inc.)
(1998)

VisiTek, Inc.

Machine vision intelligent systems
(1998)

CardioGene Therapeutics

CardioGene is focused on the development of novel gene therapy products for the treatment of cardiovascular disease (Formerly Genocor, Inc.)
(1997)

Michigan Aerospace, Inc.

Light Detection and Ranging (LIDAR) and related optical systems for atmospheric measurement
(1997)

Mitex Solutions, Inc.

Run-to-run controllers for semiconductors
(1997)

Biotherapies, Inc.

Commercializing Mammastatin Serum Assay technology used to screen breast cancer risk
(1996)

PicoMetrix, Inc.

High-speed optical sensing devices
(1996)

IDUN Pharmaceuticals, Inc.

Therapeutic applications focused on inhibiting caspase activity as treatments for liver disease and inflammation
(1994)

Targeted Genetics

Molecular medicines for disease detection and prevention (Formerly Genevo)
(1994)

Vetgen, Inc.

Research and genetic disease detection services for all purebred animals
(1994)

Audiocomp, Inc.

Digital audio compression system
(1993)

GlycoGen

Developing immunomodulatory & anti-inflammatory therapeutics based on cell adhesion technology
(1992)

K-Space Associates, Inc.

Optical imaging using in-situ thin-film and wafer characterization technologies
(1992)

SoloHill Engineering, Inc.

Microcarriers and protocols for cell culture applications
(1992)

MC3

MC3 Cardiopulmonary, located in Dexter, was founded in 1991 by Robert Bartlett, M.D., a pioneering University of Michigan surgeon, and Scott Merz, PhD, to develop Extracorporeal Membrane Oxygenation (ECMO) technology for patients who would otherwise succumb to heart and lung disease.
(1991)